1-11 of 11
Hui Yin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes

Richeek Pradhan, Hui Yin, Sally Lu, Giada Sebastiani, Oriana Yu, Samy Suissa, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2025;48(3):444–454
https://doi.org/10.2337/dc24-1903
Published: 08 January 2025
View article titled, Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study

Devin Abrahami, Helen Tesfaye, Hui Yin, Seanna Vine, Blánaid Hicks, Oriana H.Y. Yu, Lysanne Campeau, Robert W. Platt, Sebastian Schneeweiss, Elisabetta Patorno, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2022;45(12):2907–2917
https://doi.org/10.2337/dc22-1174
Published: 28 September 2022
View article titled, Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study in another window
Journal Articles

Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes

Richeek Pradhan, Hui Yin, Oriana H.Y. Yu, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2022;45(10):2289–2298
https://doi.org/10.2337/dc22-0712
Published: 22 July 2022
View article titled, Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes
Open the PDF for Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes in another window
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes

Richeek Pradhan, Hui Yin, Oriana Yu, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2022;45(4):819–829
https://doi.org/10.2337/dc21-1953
Published: 01 February 2022
View article titled, Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes

Melanie Suissa, Hui Yin, Oriana H.Y. Yu, Stephanie M. Wong, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2021;44(1):e9–e11
https://doi.org/10.2337/dc20-1073
Published: 06 November 2020
View article titled, Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Devin Abrahami, Antonios Douros, Hui Yin, Oriana H.Y. Yu, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2019;42(9):e150–e152
https://doi.org/10.2337/dc19-0849
Published: 11 July 2019
View article titled, Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes in another window
Journal Articles

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes

Antonios Douros, Julie Rouette, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2019;42(8):1496–1503
https://doi.org/10.2337/dc19-0409
Published: 10 June 2019
View article titled, Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
Open the PDF for Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy

Antonios Douros, Kristian B. Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A. Udell, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2018;41(11):2330–2338
https://doi.org/10.2337/dc17-2280
Published: 27 August 2018
View article titled, Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy in another window
Includes: Supplementary data
Journal Articles

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Samy Suissa
Journal: Diabetes Care
Diabetes Care 2017;40(11):1506–1513
https://doi.org/10.2337/dc17-0595
Published: 01 September 2017
View article titled, Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
Open the PDF for Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events in another window
Includes: Supplementary data
Journal Articles

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes

Marco Tuccori, Jennifer W. Wu, Hui Yin, Agnieszka Majdan, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2015;38(11):2083–2089
https://doi.org/10.2337/dc15-1358
Published: 04 September 2015
View article titled, The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
Open the PDF for The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes

Brielan B. Smiechowski, MSC, Laurent Azoulay, PHD, Hui Yin, MSC, Michael N. Pollak, MD, Samy Suissa, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(1):124–129
https://doi.org/10.2337/dc12-0740
Published: 11 December 2012
View article titled, The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
Open the PDF for The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes in another window